171 related articles for article (PubMed ID: 33054858)
1. Enhancer of mRNA Decapping protein 4 (EDC4) interacts with replication protein a (RPA) and contributes to Cisplatin resistance in cervical Cancer by alleviating DNA damage.
Wu X; Zhong Y; Chen Q; Zhang X; Zhang H
Hereditas; 2020 Oct; 157(1):41. PubMed ID: 33054858
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells.
Xia J; Yu X; Song X; Li G; Mao X; Zhang Y
Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427
[TBL] [Abstract][Full Text] [Related]
3. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
Wang T; Liu Z; Shi F; Wang J
Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
[TBL] [Abstract][Full Text] [Related]
5. PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway.
Duan W; Liu X
Ann Clin Lab Sci; 2020 Jul; 50(4):512-518. PubMed ID: 32826249
[TBL] [Abstract][Full Text] [Related]
6. Cyclin I promotes cisplatin resistance via Cdk5 activation in cervical cancer.
Li R; Liu GZ; Luo SY; Chen R; Zhang JX
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4533-41. PubMed ID: 26698249
[TBL] [Abstract][Full Text] [Related]
7. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
Cai L; Wang Z; Liu D
Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
[TBL] [Abstract][Full Text] [Related]
8. Aberrantly Expressed Timeless Regulates Cell Proliferation and Cisplatin Efficacy in Cervical Cancer.
Zhou J; Zhang Y; Zou X; Kuai L; Wang L; Wang J; Shen F; Hu J; Zhang X; Huang Y; Chen Y
Hum Gene Ther; 2020 Mar; 31(5-6):385-395. PubMed ID: 31870179
[TBL] [Abstract][Full Text] [Related]
9. FOXM1 Contributes to Chemotherapy Sensitivity in Cervical Cancer by Regulating TTK.
Tang Q; Xu A; Yang Y; Zhang Y; Sun J
Discov Med; 2023 Jun; 35(176):208-220. PubMed ID: 37272088
[TBL] [Abstract][Full Text] [Related]
10. SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines.
Chen X; Xiong D; Ye L; Yang H; Mei S; Wu J; Chen S; Mi R
Cancer Chemother Pharmacol; 2019 Apr; 83(4):603-613. PubMed ID: 30627777
[TBL] [Abstract][Full Text] [Related]
11. Biological and chemical inhibitors of NF-kappaB sensitize SiHa cells to cisplatin-induced apoptosis.
Venkatraman M; Anto RJ; Nair A; Varghese M; Karunagaran D
Mol Carcinog; 2005 Sep; 44(1):51-9. PubMed ID: 16044419
[TBL] [Abstract][Full Text] [Related]
12. [EBF1 Promotes the Sensitivity of Cervical Cancer Cells to Cisplatin via Activating FBN1 Transcription].
Shen NN; Lin JH; Liu PP
Mol Biol (Mosk); 2023; 57(3):503-504. PubMed ID: 37326054
[TBL] [Abstract][Full Text] [Related]
13. NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
Tao T; Yang X; Qin Q; Shi W; Wang Q; Yang Y; He J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085111
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer.
Zhou Y; Liu F; Xu Q; Yang B; Li X; Jiang S; Hu L; Zhang X; Zhu L; Li Q; Zhu X; Shao H; Dai M; Shen Y; Ni B; Wang S; Zhang Z; Teng Y
Oncogene; 2020 Aug; 39(34):5633-5648. PubMed ID: 32661323
[TBL] [Abstract][Full Text] [Related]
15. iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling.
Xiong Y; Sun F; Dong P; Watari H; Yue J; Yu MF; Lan CY; Wang Y; Ma ZB
J Exp Clin Cancer Res; 2017 Apr; 36(1):48. PubMed ID: 28399926
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin regulates DNA repair responding to ionizing radiation and enhances radiosensitivity of human cervical cancer cells.
Yang YC; Chao KS; Lin CP; Chen YY; Wang KL; Chen YJ
Int J Gynecol Cancer; 2009 May; 19(4):782-6. PubMed ID: 19509588
[TBL] [Abstract][Full Text] [Related]
17. Contribution of organic cation transporter 3 to cisplatin cytotoxicity in human cervical cancer cells.
Li Q; Peng X; Yang H; Rodriguez JA; Shu Y
J Pharm Sci; 2012 Jan; 101(1):394-404. PubMed ID: 21905038
[TBL] [Abstract][Full Text] [Related]
18. Low GAS5 expression may predict poor survival and cisplatin resistance in cervical cancer.
Fang X; Zhong G; Wang Y; Lin Z; Lin R; Yao T
Cell Death Dis; 2020 Jul; 11(7):531. PubMed ID: 32661236
[TBL] [Abstract][Full Text] [Related]
19. L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation.
Wagner W; Ciszewski WM; Kania KD
Cell Commun Signal; 2015 Jul; 13():36. PubMed ID: 26208712
[TBL] [Abstract][Full Text] [Related]
20. Vitamin C in synergism with cisplatin induces cell death in cervical cancer cells through altered redox cycling and p53 upregulation.
Leekha A; Gurjar BS; Tyagi A; Rizvi MA; Verma AK
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2503-2514. PubMed ID: 27613187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
